Exhibit 107
CALCULATION OF FILING FEE TABLE
Form 424(b)(5)
(Form Type)
Nurix Therapeutics, Inc.
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered Securities
| Security Type |
Title of Each Class of Securities to be Registered |
Fee Calculation Rule |
Amount to be Registered(1) |
Proposed Maximum Offering Price Per Share |
Maximum Aggregate Offering Price |
Fee Rate |
Amount of Registration Fee(2) | |||||||||
| Fees to be Paid | Equity | Common stock, par value $0.001 per share | Rule 457(c) and Rule 457(r) |
— | — | $150,000,000 | $0.00014760 | $22,140 | ||||||||
| Fees Previously Paid |
— | — | — | — | — | — | — | — | ||||||||
| Total Offering Amounts | — | $150,000,000 | — | $22,140 | ||||||||||||
| Total Fees Previously Paid | — | — | — | — | ||||||||||||
| Total Fee Offsets | — | — | — | — | ||||||||||||
| Net Fee Due | — | — | — | $22,140 | ||||||||||||
| (1) | Consists of shares to be issued pursuant to that certain Equity Distribution Agreement dated August 4, 2021 (as amended by Amendment No. 1 dated July 11, 2024), by and between the Registrant and Piper Sandler & Co. |
| (2) | Calculated in accordance with Rule 457(c) and Rule 457(r) under the Securities Act of 1933, as amended. Represents payment of registration fees previously deferred in connection with the automatic registration statement on Form S-3 (Registration No. 333-280117). |